(Q46665884)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16118250%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Increased plasma adiponectin in response to pioglitazone does not result from increased gene expression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16118250%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16118250%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Aiwei Yao-Borengasser

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16118250%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Leslie M Miles

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16118250%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Steven C Elbein

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16118250%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Philip A Kern

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16118250%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

23 August 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16118250%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Physiology - Endocrinology and Metabolism

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16118250%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

290

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16118250%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16118250%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

E42-E46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16118250%20AND%20SRC:MED&resulttype=core&format=json

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

Effects of pioglitazone in nondiabetic patients with arterial hypertension: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

Rosiglitazone but not metformin enhances insulin- and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

Adiponectin and adiponectin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

Adiponectin and development of type 2 diabetes in the Pima Indian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

Identification and adipocyte differentiation-dependent expression of the unique disialic acid residue in an adipose tissue-specific glycoprotein, adipo Q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

The hormone resistin links obesity to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

Adiponectin--journey from an adipocyte secretory protein to biomarker of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

Adiponectin: a link between excess adiposity and associated comorbidities?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin. Potential role in the modulation of its insulin-sensitizing activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005

The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00240.2005